I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Tuberculosis
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Tuberculosis Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Tuberculosis Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Chest X-Ray by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Chest X-Ray by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Chest X-Ray by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Culture Based
Tests by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Culture Based Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Culture Based Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for IGRA
(Interferon-Gamma Release Assays) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for IGRA (Interferon-Gamma
Release Assays) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for IGRA (Interferon-Gamma
Release Assays) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 13: World Current & Future Analysis for Nucleic Acid
Testing (NAT) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Nucleic Acid Testing (NAT)
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Nucleic Acid Testing
(NAT) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 16: World Current & Future Analysis for Smear Microscopy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Smear Microscopy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Smear Microscopy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Serological Tests
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Serological Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Serological Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other Test Types
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Other Test Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other Test Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Academics &
Research by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Academics & Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Academics & Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Hospitals
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Hospitals Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Hospitals Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Physicians Office
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 32: World Historic Review for Physicians Office
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Physicians Office
Laboratories by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 34: World Current & Future Analysis for Reference
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 35: World Historic Review for Reference Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Reference Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 37: USA Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Tuberculosis Testing by Test
Type - Chest X-Ray, Culture Based Tests, IGRA (Interferon-Gamma
Release Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 39: USA 15-Year Perspective for Tuberculosis Testing by
Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 40: USA Current & Future Analysis for Tuberculosis
Testing by End-Use - Academics & Research, Hospitals
Laboratories, Physicians Office Laboratories and Reference
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Tuberculosis Testing by
End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

CANADA
Table 43: Canada Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Tuberculosis Testing by
Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Tuberculosis Testing
by Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 46: Canada Current & Future Analysis for Tuberculosis
Testing by End-Use - Academics & Research, Hospitals
Laboratories, Physicians Office Laboratories and Reference
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Tuberculosis Testing
by End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

JAPAN
Table 49: Japan Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Tuberculosis Testing by
Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Tuberculosis Testing by
Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 52: Japan Current & Future Analysis for Tuberculosis
Testing by End-Use - Academics & Research, Hospitals
Laboratories, Physicians Office Laboratories and Reference
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Tuberculosis Testing by
End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Tuberculosis Testing by
Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 57: China 15-Year Perspective for Tuberculosis Testing by
Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 58: China Current & Future Analysis for Tuberculosis
Testing by End-Use - Academics & Research, Hospitals
Laboratories, Physicians Office Laboratories and Reference
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Tuberculosis Testing by
End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

EUROPE
Table 61: Europe Current & Future Analysis for Tuberculosis
Testing by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 62: Europe Historic Review for Tuberculosis Testing by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 63: Europe 15-Year Perspective for Tuberculosis Testing
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 64: Europe Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Tuberculosis Testing by
Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Tuberculosis Testing
by Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 67: Europe Current & Future Analysis for Tuberculosis
Testing by End-Use - Academics & Research, Hospitals
Laboratories, Physicians Office Laboratories and Reference
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Tuberculosis Testing
by End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

FRANCE
Table 70: France Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 71: France Historic Review for Tuberculosis Testing by
Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 72: France 15-Year Perspective for Tuberculosis Testing
by Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 73: France Current & Future Analysis for Tuberculosis
Testing by End-Use - Academics & Research, Hospitals
Laboratories, Physicians Office Laboratories and Reference
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 74: France Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 75: France 15-Year Perspective for Tuberculosis Testing
by End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

GERMANY
Table 76: Germany Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 77: Germany Historic Review for Tuberculosis Testing by
Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 78: Germany 15-Year Perspective for Tuberculosis Testing
by Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 79: Germany Current & Future Analysis for Tuberculosis
Testing by End-Use - Academics & Research, Hospitals
Laboratories, Physicians Office Laboratories and Reference
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 80: Germany Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 81: Germany 15-Year Perspective for Tuberculosis Testing
by End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

ITALY
Table 82: Italy Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 83: Italy Historic Review for Tuberculosis Testing by
Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 84: Italy 15-Year Perspective for Tuberculosis Testing by
Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 85: Italy Current & Future Analysis for Tuberculosis
Testing by End-Use - Academics & Research, Hospitals
Laboratories, Physicians Office Laboratories and Reference
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 86: Italy Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 87: Italy 15-Year Perspective for Tuberculosis Testing by
End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

UNITED KINGDOM
Table 88: UK Current & Future Analysis for Tuberculosis Testing
by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 89: UK Historic Review for Tuberculosis Testing by Test
Type - Chest X-Ray, Culture Based Tests, IGRA (Interferon-Gamma
Release Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 90: UK 15-Year Perspective for Tuberculosis Testing by
Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 91: UK Current & Future Analysis for Tuberculosis Testing
by End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 92: UK Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 93: UK 15-Year Perspective for Tuberculosis Testing by
End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

SPAIN
Table 94: Spain Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 95: Spain Historic Review for Tuberculosis Testing by
Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 96: Spain 15-Year Perspective for Tuberculosis Testing by
Test Type - Percentage Breakdown of Value Sales for Chest
X-Ray, Culture Based Tests, IGRA (Interferon-Gamma Release
Assays), Nucleic Acid Testing (NAT), Smear Microscopy,
Serological Tests and Other Test Types for the Years 2012, 2020 &
2027

Table 97: Spain Current & Future Analysis for Tuberculosis
Testing by End-Use - Academics & Research, Hospitals
Laboratories, Physicians Office Laboratories and Reference
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 98: Spain Historic Review for Tuberculosis Testing by
End-Use - Academics & Research, Hospitals Laboratories,
Physicians Office Laboratories and Reference Laboratories
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 99: Spain 15-Year Perspective for Tuberculosis Testing by
End-Use - Percentage Breakdown of Value Sales for Academics &
Research, Hospitals Laboratories, Physicians Office
Laboratories and Reference Laboratories for the Years 2012,
2020 & 2027

RUSSIA
Table 100: Russia Current & Future Analysis for Tuberculosis
Testing by Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nucleic Acid Testing (NAT),
Smear Microscopy, Serological Tests and Other Test Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 101: Russia Historic Review for Tuberculosis Testing by
Test Type - Chest X-Ray, Culture Based Tests, IGRA
(Interferon-Gamma Release Assays), Nu